Clinical Trial Update: Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of ALK-depot SQ Mites in subjects with Atopic Dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ALK-depot SQ Mites

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED